MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

Search

Gimv NV

Nyitva

SzektorPénzügy

44.05 -1.45

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

44

Maximum

44.9

Fő mutatók

By Trading Economics

Bevétel

127M

Értékesítés

-49M

65M

P/E

Szektor átlag

7.709

27.185

Egy részvényre jutó nyereség

3.4

Osztalékhozam

5.71

Profit margin

195.239

Munkavállalók

94

EBITDA

52M

128M

Osztalékok

By Dow Jones

Osztalékhozam

Szektor átlag

5.71%

4.21%

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

53M

1.7B

Előző nyitás

45.5

Előző zárás

44.05

Hangulat hírek alapján

By Acuity

50%

50%

171 / 445 Rangsor szerint Finance

Gimv NV Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. febr. 5. 00:00 UTC

Forró részvények

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

2026. febr. 4. 22:55 UTC

Eredményjelentés

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

2026. febr. 4. 21:44 UTC

Eredményjelentés

Arm Holdings 3Q Profit Falls Despite Revenue Growth

2026. febr. 4. 21:39 UTC

Eredményjelentés

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

2026. febr. 5. 00:00 UTC

Eredményjelentés

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

2026. febr. 5. 00:00 UTC

Eredményjelentés

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

2026. febr. 4. 23:46 UTC

Piaci beszéd

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

2026. febr. 4. 23:45 UTC

Eredményjelentés

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

2026. febr. 4. 23:32 UTC

Piaci beszéd

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

2026. febr. 4. 22:59 UTC

Felvásárlások, összeolvadások, átvételek

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

2026. febr. 4. 22:30 UTC

Eredményjelentés

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

2026. febr. 4. 22:30 UTC

Eredményjelentés

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

2026. febr. 4. 22:21 UTC

Eredményjelentés

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026. febr. 4. 22:17 UTC

Piaci beszéd

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

2026. febr. 4. 22:15 UTC

Piaci beszéd

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

2026. febr. 4. 22:00 UTC

Piaci beszéd

ESG Roundup: Market Talk

2026. febr. 4. 21:53 UTC

Eredményjelentés

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

2026. febr. 4. 21:51 UTC

Eredményjelentés

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026. febr. 4. 21:50 UTC

Piaci beszéd

Tech, Media & Telecom Roundup: Market Talk

2026. febr. 4. 21:50 UTC

Piaci beszéd
Felvásárlások, összeolvadások, átvételek

Financial Services Roundup: Market Talk

2026. febr. 4. 21:50 UTC

Piaci beszéd
Eredményjelentés

Auto & Transport Roundup: Market Talk

2026. febr. 4. 21:50 UTC

Piaci beszéd

Health Care Roundup: Market Talk

2026. febr. 4. 21:45 UTC

Eredményjelentés

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

2026. febr. 4. 21:44 UTC

Eredményjelentés

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

2026. febr. 4. 21:43 UTC

Eredményjelentés

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

2026. febr. 4. 21:41 UTC

Eredményjelentés

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

2026. febr. 4. 21:36 UTC

Piaci beszéd

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

2026. febr. 4. 21:30 UTC

Eredményjelentés

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026. febr. 4. 21:30 UTC

Eredményjelentés

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026. febr. 4. 21:30 UTC

Eredményjelentés

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Társak összehasonlítása

Árváltozás

Gimv NV Előrejelzés

Értékelési konszenzus

By TipRanks

0 ratings

0

Vétel

0

Tartás

0

Eladás

Hangulat

By Acuity

171 / 445 Rangsor szerint Pénzügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat